logo
NasdaqCM:RNXT logo

RenovoRx Community

NasdaqCM:RNXT Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

Community Investing Ideas

RNXT logo
RenovoRx
ST
Stock_Research_Today
Community Contributor

Revolutionizing Cancer Treatment

A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.
View narrative
US$4.20
FV
76.4% undervalued intrinsic discount
371.30%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Updated narrative